 LEXINGTON, Mass.--BUSINESS WIRE--Aldeyra Therapeutics, Inc. Nasdaq: ALDX Aldeyra today announced that President and CEO Todd C. Brady, M.D., Ph.D., will discuss Aldeyras novel therapeutic approaches to treating anterior and posterior segment ocular disease at the Eyecelerator 2020 Virtual Conference on Friday, November 6, 2020. Dr. Bradys presentation is scheduled begin at 1:19 p.m. PT 4:19 p.m. ET as part of Company Showcase III, Advancing Trials in the Public Eye. The presentation 